 | • レポートコード：MRC2-11QY07177 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は白血球表面抗原CD47のグローバル市場について調査・分析したレポートです。種類別（B-6H12、ALX-148、CC-90002、PSTx-23、その他）市場規模、用途別（リンパ腫、卵巣癌、虚血再灌流障害、腎臓移植拒絶反応、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別白血球表面抗原CD47の競争状況、市場シェア ・世界の白血球表面抗原CD47市場：種類別市場規模 2015年-2020年（B-6H12、ALX-148、CC-90002、PSTx-23、その他） ・世界の白血球表面抗原CD47市場：種類別市場規模予測 2021年-2026年（B-6H12、ALX-148、CC-90002、PSTx-23、その他） ・世界の白血球表面抗原CD47市場：用途別市場規模 2015年-2020年（リンパ腫、卵巣癌、虚血再灌流障害、腎臓移植拒絶反応、その他） ・世界の白血球表面抗原CD47市場：用途別市場規模予測 2021年-2026年（リンパ腫、卵巣癌、虚血再灌流障害、腎臓移植拒絶反応、その他） ・北米の白血球表面抗原CD47市場分析：米国、カナダ ・ヨーロッパの白血球表面抗原CD47市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの白血球表面抗原CD47市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の白血球表面抗原CD47市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの白血球表面抗原CD47市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Aurigene Discovery Technologies Ltd、Celgene Corp、Forty Seven Inc、Surface Oncology Inc、Trillium Therapeutics Inc ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Leukocyte Surface Antigen CD47 Market
The global Leukocyte Surface Antigen CD47 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Leukocyte Surface Antigen CD47 Scope and Market Size
Leukocyte Surface Antigen CD47 market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Leukocyte Surface Antigen CD47 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Leukocyte Surface Antigen CD47 market is segmented into
B-6H12
ALX-148
CC-90002
PSTx-23
Others
Segment by Application, the Leukocyte Surface Antigen CD47 market is segmented into
Lymphoma
Ovarian Cancer
Ischemia Reperfusion Injury
Kindney Transplant Rejection
Others
Regional and Country-level Analysis
The Leukocyte Surface Antigen CD47 market is analysed and market size information is provided by regions (countries).
The key regions covered in the Leukocyte Surface Antigen CD47 market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Leukocyte Surface Antigen CD47 Market Share Analysis
Leukocyte Surface Antigen CD47 market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Leukocyte Surface Antigen CD47 business, the date to enter into the Leukocyte Surface Antigen CD47 market, Leukocyte Surface Antigen CD47 product introduction, recent developments, etc.
The major vendors covered:
Aurigene Discovery Technologies Ltd
Celgene Corp
Forty Seven Inc
Surface Oncology Inc
Trillium Therapeutics Inc
…
1 Study Coverage
1.1 Leukocyte Surface Antigen CD47 Product Introduction
1.2 Market Segments
1.3 Key Leukocyte Surface Antigen CD47 Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Leukocyte Surface Antigen CD47 Market Size Growth Rate by Type
1.4.2 B-6H12
1.4.3 ALX-148
1.4.4 CC-90002
1.4.5 PSTx-23
1.4.6 Others
1.5 Market by Application
1.5.1 Global Leukocyte Surface Antigen CD47 Market Size Growth Rate by Application
1.5.2 Lymphoma
1.5.3 Ovarian Cancer
1.5.4 Ischemia Reperfusion Injury
1.5.5 Kindney Transplant Rejection
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Leukocyte Surface Antigen CD47 Market Size, Estimates and Forecasts
2.1.1 Global Leukocyte Surface Antigen CD47 Revenue 2015-2026
2.1.2 Global Leukocyte Surface Antigen CD47 Sales 2015-2026
2.2 Global Leukocyte Surface Antigen CD47, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Leukocyte Surface Antigen CD47 Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Leukocyte Surface Antigen CD47 Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Leukocyte Surface Antigen CD47 Competitor Landscape by Players
3.1 Leukocyte Surface Antigen CD47 Sales by Manufacturers
3.1.1 Leukocyte Surface Antigen CD47 Sales by Manufacturers (2015-2020)
3.1.2 Leukocyte Surface Antigen CD47 Sales Market Share by Manufacturers (2015-2020)
3.2 Leukocyte Surface Antigen CD47 Revenue by Manufacturers
3.2.1 Leukocyte Surface Antigen CD47 Revenue by Manufacturers (2015-2020)
3.2.2 Leukocyte Surface Antigen CD47 Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Leukocyte Surface Antigen CD47 Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Leukocyte Surface Antigen CD47 Revenue in 2019
3.2.5 Global Leukocyte Surface Antigen CD47 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Leukocyte Surface Antigen CD47 Price by Manufacturers
3.4 Leukocyte Surface Antigen CD47 Manufacturing Base Distribution, Product Types
3.4.1 Leukocyte Surface Antigen CD47 Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Leukocyte Surface Antigen CD47 Product Type
3.4.3 Date of International Manufacturers Enter into Leukocyte Surface Antigen CD47 Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Leukocyte Surface Antigen CD47 Market Size by Type (2015-2020)
4.1.1 Global Leukocyte Surface Antigen CD47 Sales by Type (2015-2020)
4.1.2 Global Leukocyte Surface Antigen CD47 Revenue by Type (2015-2020)
4.1.3 Leukocyte Surface Antigen CD47 Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Leukocyte Surface Antigen CD47 Market Size Forecast by Type (2021-2026)
4.2.1 Global Leukocyte Surface Antigen CD47 Sales Forecast by Type (2021-2026)
4.2.2 Global Leukocyte Surface Antigen CD47 Revenue Forecast by Type (2021-2026)
4.2.3 Leukocyte Surface Antigen CD47 Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Leukocyte Surface Antigen CD47 Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Leukocyte Surface Antigen CD47 Market Size by Application (2015-2020)
5.1.1 Global Leukocyte Surface Antigen CD47 Sales by Application (2015-2020)
5.1.2 Global Leukocyte Surface Antigen CD47 Revenue by Application (2015-2020)
5.1.3 Leukocyte Surface Antigen CD47 Price by Application (2015-2020)
5.2 Leukocyte Surface Antigen CD47 Market Size Forecast by Application (2021-2026)
5.2.1 Global Leukocyte Surface Antigen CD47 Sales Forecast by Application (2021-2026)
5.2.2 Global Leukocyte Surface Antigen CD47 Revenue Forecast by Application (2021-2026)
5.2.3 Global Leukocyte Surface Antigen CD47 Price Forecast by Application (2021-2026)
6 North America
6.1 North America Leukocyte Surface Antigen CD47 by Country
6.1.1 North America Leukocyte Surface Antigen CD47 Sales by Country
6.1.2 North America Leukocyte Surface Antigen CD47 Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Leukocyte Surface Antigen CD47 Market Facts & Figures by Type
6.3 North America Leukocyte Surface Antigen CD47 Market Facts & Figures by Application
7 Europe
7.1 Europe Leukocyte Surface Antigen CD47 by Country
7.1.1 Europe Leukocyte Surface Antigen CD47 Sales by Country
7.1.2 Europe Leukocyte Surface Antigen CD47 Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Leukocyte Surface Antigen CD47 Market Facts & Figures by Type
7.3 Europe Leukocyte Surface Antigen CD47 Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Leukocyte Surface Antigen CD47 by Region
8.1.1 Asia Pacific Leukocyte Surface Antigen CD47 Sales by Region
8.1.2 Asia Pacific Leukocyte Surface Antigen CD47 Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Leukocyte Surface Antigen CD47 Market Facts & Figures by Type
8.3 Asia Pacific Leukocyte Surface Antigen CD47 Market Facts & Figures by Application
9 Latin America
9.1 Latin America Leukocyte Surface Antigen CD47 by Country
9.1.1 Latin America Leukocyte Surface Antigen CD47 Sales by Country
9.1.2 Latin America Leukocyte Surface Antigen CD47 Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Leukocyte Surface Antigen CD47 Market Facts & Figures by Type
9.3 Central & South America Leukocyte Surface Antigen CD47 Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Leukocyte Surface Antigen CD47 by Country
10.1.1 Middle East and Africa Leukocyte Surface Antigen CD47 Sales by Country
10.1.2 Middle East and Africa Leukocyte Surface Antigen CD47 Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Leukocyte Surface Antigen CD47 Market Facts & Figures by Type
10.3 Middle East and Africa Leukocyte Surface Antigen CD47 Market Facts & Figures by Application
11 Company Profiles
11.1 Aurigene Discovery Technologies Ltd
11.1.1 Aurigene Discovery Technologies Ltd Corporation Information
11.1.2 Aurigene Discovery Technologies Ltd Description and Business Overview
11.1.3 Aurigene Discovery Technologies Ltd Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Aurigene Discovery Technologies Ltd Leukocyte Surface Antigen CD47 Products Offered
11.1.5 Aurigene Discovery Technologies Ltd Related Developments
11.2 Celgene Corp
11.2.1 Celgene Corp Corporation Information
11.2.2 Celgene Corp Description and Business Overview
11.2.3 Celgene Corp Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Celgene Corp Leukocyte Surface Antigen CD47 Products Offered
11.2.5 Celgene Corp Related Developments
11.3 Forty Seven Inc
11.3.1 Forty Seven Inc Corporation Information
11.3.2 Forty Seven Inc Description and Business Overview
11.3.3 Forty Seven Inc Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Forty Seven Inc Leukocyte Surface Antigen CD47 Products Offered
11.3.5 Forty Seven Inc Related Developments
11.4 Surface Oncology Inc
11.4.1 Surface Oncology Inc Corporation Information
11.4.2 Surface Oncology Inc Description and Business Overview
11.4.3 Surface Oncology Inc Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Surface Oncology Inc Leukocyte Surface Antigen CD47 Products Offered
11.4.5 Surface Oncology Inc Related Developments
11.5 Trillium Therapeutics Inc
11.5.1 Trillium Therapeutics Inc Corporation Information
11.5.2 Trillium Therapeutics Inc Description and Business Overview
11.5.3 Trillium Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Trillium Therapeutics Inc Leukocyte Surface Antigen CD47 Products Offered
11.5.5 Trillium Therapeutics Inc Related Developments
11.1 Aurigene Discovery Technologies Ltd
11.1.1 Aurigene Discovery Technologies Ltd Corporation Information
11.1.2 Aurigene Discovery Technologies Ltd Description and Business Overview
11.1.3 Aurigene Discovery Technologies Ltd Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Aurigene Discovery Technologies Ltd Leukocyte Surface Antigen CD47 Products Offered
11.1.5 Aurigene Discovery Technologies Ltd Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Leukocyte Surface Antigen CD47 Market Estimates and Projections by Region
12.1.1 Global Leukocyte Surface Antigen CD47 Sales Forecast by Regions 2021-2026
12.1.2 Global Leukocyte Surface Antigen CD47 Revenue Forecast by Regions 2021-2026
12.2 North America Leukocyte Surface Antigen CD47 Market Size Forecast (2021-2026)
12.2.1 North America: Leukocyte Surface Antigen CD47 Sales Forecast (2021-2026)
12.2.2 North America: Leukocyte Surface Antigen CD47 Revenue Forecast (2021-2026)
12.2.3 North America: Leukocyte Surface Antigen CD47 Market Size Forecast by Country (2021-2026)
12.3 Europe Leukocyte Surface Antigen CD47 Market Size Forecast (2021-2026)
12.3.1 Europe: Leukocyte Surface Antigen CD47 Sales Forecast (2021-2026)
12.3.2 Europe: Leukocyte Surface Antigen CD47 Revenue Forecast (2021-2026)
12.3.3 Europe: Leukocyte Surface Antigen CD47 Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Leukocyte Surface Antigen CD47 Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Leukocyte Surface Antigen CD47 Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Leukocyte Surface Antigen CD47 Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Leukocyte Surface Antigen CD47 Market Size Forecast by Region (2021-2026)
12.5 Latin America Leukocyte Surface Antigen CD47 Market Size Forecast (2021-2026)
12.5.1 Latin America: Leukocyte Surface Antigen CD47 Sales Forecast (2021-2026)
12.5.2 Latin America: Leukocyte Surface Antigen CD47 Revenue Forecast (2021-2026)
12.5.3 Latin America: Leukocyte Surface Antigen CD47 Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Leukocyte Surface Antigen CD47 Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Leukocyte Surface Antigen CD47 Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Leukocyte Surface Antigen CD47 Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Leukocyte Surface Antigen CD47 Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Leukocyte Surface Antigen CD47 Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Leukocyte Surface Antigen CD47 Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Leukocyte Surface Antigen CD47 Market Segments
Table 2. Ranking of Global Top Leukocyte Surface Antigen CD47 Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Leukocyte Surface Antigen CD47 Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of B-6H12
Table 5. Major Manufacturers of ALX-148
Table 6. Major Manufacturers of CC-90002
Table 7. Major Manufacturers of PSTx-23
Table 8. Major Manufacturers of Others
Table 9. Global Leukocyte Surface Antigen CD47 Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Leukocyte Surface Antigen CD47 Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Leukocyte Surface Antigen CD47 Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Leukocyte Surface Antigen CD47 Sales Market Share by Regions (2015-2020)
Table 13. Global Leukocyte Surface Antigen CD47 Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Leukocyte Surface Antigen CD47 Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Leukocyte Surface Antigen CD47 Sales Share by Manufacturers (2015-2020)
Table 16. Global Leukocyte Surface Antigen CD47 Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Leukocyte Surface Antigen CD47 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Leukocyte Surface Antigen CD47 as of 2019)
Table 18. Leukocyte Surface Antigen CD47 Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Leukocyte Surface Antigen CD47 Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Leukocyte Surface Antigen CD47 Price (2015-2020) (USD/Pcs)
Table 21. Leukocyte Surface Antigen CD47 Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Leukocyte Surface Antigen CD47 Product Type
Table 23. Date of International Manufacturers Enter into Leukocyte Surface Antigen CD47 Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Leukocyte Surface Antigen CD47 Sales by Type (2015-2020) (K Pcs)
Table 26. Global Leukocyte Surface Antigen CD47 Sales Share by Type (2015-2020)
Table 27. Global Leukocyte Surface Antigen CD47 Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Leukocyte Surface Antigen CD47 Revenue Share by Type (2015-2020)
Table 29. Leukocyte Surface Antigen CD47 Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Leukocyte Surface Antigen CD47 Sales by Application (2015-2020) (K Pcs)
Table 31. Global Leukocyte Surface Antigen CD47 Sales Share by Application (2015-2020)
Table 32. North America Leukocyte Surface Antigen CD47 Sales by Country (2015-2020) (K Pcs)
Table 33. North America Leukocyte Surface Antigen CD47 Sales Market Share by Country (2015-2020)
Table 34. North America Leukocyte Surface Antigen CD47 Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Leukocyte Surface Antigen CD47 Revenue Market Share by Country (2015-2020)
Table 36. North America Leukocyte Surface Antigen CD47 Sales by Type (2015-2020) (K Pcs)
Table 37. North America Leukocyte Surface Antigen CD47 Sales Market Share by Type (2015-2020)
Table 38. North America Leukocyte Surface Antigen CD47 Sales by Application (2015-2020) (K Pcs)
Table 39. North America Leukocyte Surface Antigen CD47 Sales Market Share by Application (2015-2020)
Table 40. Europe Leukocyte Surface Antigen CD47 Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Leukocyte Surface Antigen CD47 Sales Market Share by Country (2015-2020)
Table 42. Europe Leukocyte Surface Antigen CD47 Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Leukocyte Surface Antigen CD47 Revenue Market Share by Country (2015-2020)
Table 44. Europe Leukocyte Surface Antigen CD47 Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Leukocyte Surface Antigen CD47 Sales Market Share by Type (2015-2020)
Table 46. Europe Leukocyte Surface Antigen CD47 Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Leukocyte Surface Antigen CD47 Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Leukocyte Surface Antigen CD47 Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Leukocyte Surface Antigen CD47 Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Leukocyte Surface Antigen CD47 Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Leukocyte Surface Antigen CD47 Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Leukocyte Surface Antigen CD47 Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Leukocyte Surface Antigen CD47 Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Leukocyte Surface Antigen CD47 Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Leukocyte Surface Antigen CD47 Sales Market Share by Application (2015-2020)
Table 56. Latin America Leukocyte Surface Antigen CD47 Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Leukocyte Surface Antigen CD47 Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Leukocyte Surface Antigen CD47 Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Leukocyte Surface Antigen CD47 Revenue Market Share by Country (2015-2020)
Table 60. Latin America Leukocyte Surface Antigen CD47 Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Leukocyte Surface Antigen CD47 Sales Market Share by Type (2015-2020)
Table 62. Latin America Leukocyte Surface Antigen CD47 Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Leukocyte Surface Antigen CD47 Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Leukocyte Surface Antigen CD47 Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Leukocyte Surface Antigen CD47 Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Leukocyte Surface Antigen CD47 Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Leukocyte Surface Antigen CD47 Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Leukocyte Surface Antigen CD47 Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Leukocyte Surface Antigen CD47 Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Leukocyte Surface Antigen CD47 Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Leukocyte Surface Antigen CD47 Sales Market Share by Application (2015-2020)
Table 72. Aurigene Discovery Technologies Ltd Corporation Information
Table 73. Aurigene Discovery Technologies Ltd Description and Major Businesses
Table 74. Aurigene Discovery Technologies Ltd Leukocyte Surface Antigen CD47 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Aurigene Discovery Technologies Ltd Product
Table 76. Aurigene Discovery Technologies Ltd Recent Development
Table 77. Celgene Corp Corporation Information
Table 78. Celgene Corp Description and Major Businesses
Table 79. Celgene Corp Leukocyte Surface Antigen CD47 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Celgene Corp Product
Table 81. Celgene Corp Recent Development
Table 82. Forty Seven Inc Corporation Information
Table 83. Forty Seven Inc Description and Major Businesses
Table 84. Forty Seven Inc Leukocyte Surface Antigen CD47 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Forty Seven Inc Product
Table 86. Forty Seven Inc Recent Development
Table 87. Surface Oncology Inc Corporation Information
Table 88. Surface Oncology Inc Description and Major Businesses
Table 89. Surface Oncology Inc Leukocyte Surface Antigen CD47 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Surface Oncology Inc Product
Table 91. Surface Oncology Inc Recent Development
Table 92. Trillium Therapeutics Inc Corporation Information
Table 93. Trillium Therapeutics Inc Description and Major Businesses
Table 94. Trillium Therapeutics Inc Leukocyte Surface Antigen CD47 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. Trillium Therapeutics Inc Product
Table 96. Trillium Therapeutics Inc Recent Development
Table 97. Global Leukocyte Surface Antigen CD47 Sales Forecast by Regions (2021-2026) (K Pcs)
Table 98. Global Leukocyte Surface Antigen CD47 Sales Market Share Forecast by Regions (2021-2026)
Table 99. Global Leukocyte Surface Antigen CD47 Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 100. Global Leukocyte Surface Antigen CD47 Revenue Market Share Forecast by Regions (2021-2026)
Table 101. North America: Leukocyte Surface Antigen CD47 Sales Forecast by Country (2021-2026) (K Pcs)
Table 102. North America: Leukocyte Surface Antigen CD47 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 103. Europe: Leukocyte Surface Antigen CD47 Sales Forecast by Country (2021-2026) (K Pcs)
Table 104. Europe: Leukocyte Surface Antigen CD47 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 105. Asia Pacific: Leukocyte Surface Antigen CD47 Sales Forecast by Region (2021-2026) (K Pcs)
Table 106. Asia Pacific: Leukocyte Surface Antigen CD47 Revenue Forecast by Region (2021-2026) (US$ Million)
Table 107. Latin America: Leukocyte Surface Antigen CD47 Sales Forecast by Country (2021-2026) (K Pcs)
Table 108. Latin America: Leukocyte Surface Antigen CD47 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 109. Middle East and Africa: Leukocyte Surface Antigen CD47 Sales Forecast by Country (2021-2026) (K Pcs)
Table 110. Middle East and Africa: Leukocyte Surface Antigen CD47 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 111. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 112. Key Challenges
Table 113. Market Risks
Table 114. Main Points Interviewed from Key Leukocyte Surface Antigen CD47 Players
Table 115. Leukocyte Surface Antigen CD47 Customers List
Table 116. Leukocyte Surface Antigen CD47 Distributors List
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Leukocyte Surface Antigen CD47 Product Picture
Figure 2. Global Leukocyte Surface Antigen CD47 Sales Market Share by Type in 2020 & 2026
Figure 3. B-6H12 Product Picture
Figure 4. ALX-148 Product Picture
Figure 5. CC-90002 Product Picture
Figure 6. PSTx-23 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Leukocyte Surface Antigen CD47 Sales Market Share by Application in 2020 & 2026
Figure 9. Lymphoma
Figure 10. Ovarian Cancer
Figure 11. Ischemia Reperfusion Injury
Figure 12. Kindney Transplant Rejection
Figure 13. Others
Figure 14. Leukocyte Surface Antigen CD47 Report Years Considered
Figure 15. Global Leukocyte Surface Antigen CD47 Market Size 2015-2026 (US$ Million)
Figure 16. Global Leukocyte Surface Antigen CD47 Sales 2015-2026 (K Pcs)
Figure 17. Global Leukocyte Surface Antigen CD47 Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Leukocyte Surface Antigen CD47 Sales Market Share by Region (2015-2020)
Figure 19. Global Leukocyte Surface Antigen CD47 Sales Market Share by Region in 2019
Figure 20. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Region (2015-2020)
Figure 21. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Region in 2019
Figure 22. Global Leukocyte Surface Antigen CD47 Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Leukocyte Surface Antigen CD47 Revenue in 2019
Figure 24. Leukocyte Surface Antigen CD47 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Leukocyte Surface Antigen CD47 Sales Market Share by Type (2015-2020)
Figure 26. Global Leukocyte Surface Antigen CD47 Sales Market Share by Type in 2019
Figure 27. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Type (2015-2020)
Figure 28. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Type in 2019
Figure 29. Global Leukocyte Surface Antigen CD47 Market Share by Price Range (2015-2020)
Figure 30. Global Leukocyte Surface Antigen CD47 Sales Market Share by Application (2015-2020)
Figure 31. Global Leukocyte Surface Antigen CD47 Sales Market Share by Application in 2019
Figure 32. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Application (2015-2020)
Figure 33. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Application in 2019
Figure 34. North America Leukocyte Surface Antigen CD47 Sales Growth Rate 2015-2020 (K Pcs)
Figure 35. North America Leukocyte Surface Antigen CD47 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 36. North America Leukocyte Surface Antigen CD47 Sales Market Share by Country in 2019
Figure 37. North America Leukocyte Surface Antigen CD47 Revenue Market Share by Country in 2019
Figure 38. U.S. Leukocyte Surface Antigen CD47 Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. U.S. Leukocyte Surface Antigen CD47 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Canada Leukocyte Surface Antigen CD47 Sales Growth Rate (2015-2020) (K Pcs)
Figure 41. Canada Leukocyte Surface Antigen CD47 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. North America Leukocyte Surface Antigen CD47 Market Share by Type in 2019
Figure 43. North America Leukocyte Surface Antigen CD47 Market Share by Application in 2019
Figure 44. Europe Leukocyte Surface Antigen CD47 Sales Growth Rate 2015-2020 (K Pcs)
Figure 45. Europe Leukocyte Surface Antigen CD47 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe Leukocyte Surface Antigen CD47 Sales Market Share by Country in 2019
Figure 47. Europe Leukocyte Surface Antigen CD47 Revenue Market Share by Country in 2019
Figure 48. Germany Leukocyte Surface Antigen CD47 Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. Germany Leukocyte Surface Antigen CD47 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France Leukocyte Surface Antigen CD47 Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. France Leukocyte Surface Antigen CD47 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. Leukocyte Surface Antigen CD47 Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. U.K. Leukocyte Surface Antigen CD47 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy Leukocyte Surface Antigen CD47 Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Italy Leukocyte Surface Antigen CD47 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia Leukocyte Surface Antigen CD47 Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. Russia Leukocyte Surface Antigen CD47 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Europe Leukocyte Surface Antigen CD47 Market Share by Type in 2019
Figure 59. Europe Leukocyte Surface Antigen CD47 Market Share by Application in 2019
Figure 60. Asia Pacific Leukocyte Surface Antigen CD47 Sales Growth Rate 2015-2020 (K Pcs)
Figure 61. Asia Pacific Leukocyte Surface Antigen CD47 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Leukocyte Surface Antigen CD47 Sales Market Share by Region in 2019
Figure 63. Asia Pacific Leukocyte Surface Antigen CD47 Revenue Market Share by Region in 2019
Figure 64. China Leukocyte Surface Antigen CD47 Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. China Leukocyte Surface Antigen CD47 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Leukocyte Surface Antigen CD47 Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. Japan Leukocyte Surface Antigen CD47 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Leukocyte Surface Antigen CD47 Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. South Korea Leukocyte Surface Antigen CD47 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Leukocyte Surface Antigen CD47 Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. India Leukocyte Surface Antigen CD47 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Leukocyte Surface Antigen CD47 Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Australia Leukocyte Surface Antigen CD47 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Leukocyte Surface Antigen CD47 Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Taiwan Leukocyte Surface Antigen CD47 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Leukocyte Surface Antigen CD47 Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Indonesia Leukocyte Surface Antigen CD47 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Leukocyte Surface Antigen CD47 Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Thailand Leukocyte Surface Antigen CD47 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Leukocyte Surface Antigen CD47 Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Malaysia Leukocyte Surface Antigen CD47 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Leukocyte Surface Antigen CD47 Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Philippines Leukocyte Surface Antigen CD47 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam Leukocyte Surface Antigen CD47 Sales Growth Rate (2015-2020) (K Pcs)
Figure 85. Vietnam Leukocyte Surface Antigen CD47 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Asia Pacific Leukocyte Surface Antigen CD47 Market Share by Type in 2019
Figure 87. Asia Pacific Leukocyte Surface Antigen CD47 Market Share by Application in 2019
Figure 88. Latin America Leukocyte Surface Antigen CD47 Sales Growth Rate 2015-2020 (K Pcs)
Figure 89. Latin America Leukocyte Surface Antigen CD47 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America Leukocyte Surface Antigen CD47 Sales Market Share by Country in 2019
Figure 91. Latin America Leukocyte Surface Antigen CD47 Revenue Market Share by Country in 2019
Figure 92. Mexico Leukocyte Surface Antigen CD47 Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Mexico Leukocyte Surface Antigen CD47 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Brazil Leukocyte Surface Antigen CD47 Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Brazil Leukocyte Surface Antigen CD47 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Argentina Leukocyte Surface Antigen CD47 Sales Growth Rate (2015-2020) (K Pcs)
Figure 97. Argentina Leukocyte Surface Antigen CD47 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Latin America Leukocyte Surface Antigen CD47 Market Share by Type in 2019
Figure 99. Latin America Leukocyte Surface Antigen CD47 Market Share by Application in 2019
Figure 100. Middle East and Africa Leukocyte Surface Antigen CD47 Sales Growth Rate 2015-2020 (K Pcs)
Figure 101. Middle East and Africa Leukocyte Surface Antigen CD47 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa Leukocyte Surface Antigen CD47 Sales Market Share by Country in 2019
Figure 103. Middle East and Africa Leukocyte Surface Antigen CD47 Revenue Market Share by Country in 2019
Figure 104. Turkey Leukocyte Surface Antigen CD47 Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Turkey Leukocyte Surface Antigen CD47 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia Leukocyte Surface Antigen CD47 Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. Saudi Arabia Leukocyte Surface Antigen CD47 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E Leukocyte Surface Antigen CD47 Sales Growth Rate (2015-2020) (K Pcs)
Figure 109. U.A.E Leukocyte Surface Antigen CD47 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Middle East and Africa Leukocyte Surface Antigen CD47 Market Share by Type in 2019
Figure 111. Middle East and Africa Leukocyte Surface Antigen CD47 Market Share by Application in 2019
Figure 112. North America Leukocyte Surface Antigen CD47 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. North America Leukocyte Surface Antigen CD47 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Europe Leukocyte Surface Antigen CD47 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Europe Leukocyte Surface Antigen CD47 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Asia Pacific Leukocyte Surface Antigen CD47 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Asia Pacific Leukocyte Surface Antigen CD47 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Latin America Leukocyte Surface Antigen CD47 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Latin America Leukocyte Surface Antigen CD47 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Middle East and Africa Leukocyte Surface Antigen CD47 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 121. Middle East and Africa Leukocyte Surface Antigen CD47 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Porter's Five Forces Analysis
Figure 123. Channels of Distribution
Figure 124. Distributors Profiles
Figure 125. Bottom-up and Top-down Approaches for This Report
Figure 126. Data Triangulation
Figure 127. Key Executives Interviewed
癌胎児性抗原（CEA）の世界市場（～2026年） Carcinoembryonic antigen (CEA) describes a set of highly related glycoproteins involved in cell adhesion. Increasing consumption of alcohol and sedentary lifestyle are likely to boost the growth of colorectal cancer over the forecast period. Market Analysis and Insights: Global Carcinoembryonic Anti…- 前立腺特異抗原の世界市場（～2026年） Market Analysis and Insights: Global Prostate Specific Antigen Market The global Prostate Specific Antigen market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Prostate Specific Antigen Scope and Market Size Prostate Specif…
- 癌胎児性抗原関連細胞接着分子5の世界市場（～2026年） Market Analysis and Insights: Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market The global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global…
- Tリンパ球活性化抗原CD86の世界市場（～2026年） Market Analysis and Insights: Global T Lymphocyte Activation Antigen CD86 Market The global T Lymphocyte Activation Antigen CD86 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global T Lymphocyte Activation Antigen CD86 Scop…
- T細胞抗原Gp39の世界市場（～2026年） Market Analysis and Insights: Global T Cell Antigen Gp39 Market The global T Cell Antigen Gp39 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global T Cell Antigen Gp39 Scope and Market Size T Cell Antigen Gp39 market is seg…